Induction of apoptosis in the SW620 colon carcinoma cell line by triterpene-enriched extracts from Ganoderma lucidum through activation of caspase-3

Oncology Letters

Volumn 2, Issue 3, 2011, Pages 565-570

  Ji, Zhe ^a,b,c   Tang, Qingjiu ^a,b   Hao, Ruixia ^a,b   Zhang, Jinsong ^a,b   Pan, Yingjie ^d  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b INSTITUTE OF EDIBLE FUNGI   (China)

^c Chinese Academy of Sciences   (China)

^d SHANGHAI OCEAN UNIVERSITY   (China)

Author keywords

Apoptosis; Ganoderma lucidum; Triterpene

Indexed keywords

ALCOHOL; CASPASE 3; GANODERMA LUCIDUM EXTRACT; HOT WATER; MESSENGER RNA; POLYSACCHARIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TRITERPENE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CELL STRUCTURE; COLON CARCINOMA; CONCENTRATION RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GANODERMA LUCIDUM; GEL FILTRATION CHROMATOGRAPHY; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; SOLVENT EXTRACTION; UPREGULATION;

EID: 79953267207     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.275     Document Type: Article

References (37)

1. Wasson RG: Soma-Divine Mushroom of Immortality. Harcourt, Brace & World, New York, p381, 1968.
2. Chang ST and Buswell JA: Ganoderma lucidum (Curt.:Fr) P. Karst. (Aphyllophoromycetideae)-a mushrooming medicinal mushroom. International Journal of Medicinal Mushrooms 1: 139-146, 1999.
3. Wachtel-Galor S, Benzie IFF; Tomlinson B and Buswell JA: Lingzhi (Ganoderma lucidum): molecular aspects of health effects. In: Herbal Medicines. Packer L, Halliwell B and Ong CN, (eds). Marcel Dekker Inc., New York, pp179-228, 2004.
4. Furusawa E, Chou SC, Furusawa S, Hirazumi A and Dang Y: Antitumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneal implanted Lewis lung carcinoma in syngeneic mice. Phytotherapy Research 6: 300-304, 1992.
5. Lieu CW, Lee SS and Wang SY: The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res 12: 1211-1215, 1992.
6. Wang SY, Hsu ML, Hsu HC, et al: The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70: 699-705, 1997.
7. Zhu M, Chang Q, Wong LK, Chong FS and Li RC: Triterpene antioxidants from ganoderma lucidum. Phytother Res 13: 529-531, 1999.
8. Kim DH, Shim SB, Kim NJ and Jang IS: Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol Pharm Bull 22: 162-164, 1999.
9. Komoda Y, Shimizu M, Sonoda Y and Sato Y: Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem Pharma Bull 37: 531-533, 1989.
10. Kabir Y, Kimura S and Tamura T: Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol 34: 433-438, 1988.
11. Lee SY and Rhee HM: Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem Pharma Bull 38: 1359-1364, 1990.
12. Su CY, Shiao MS and Wang CT: Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets. Biochem Pharmacol 58: 587-595, 1999.
13. Gan KH, Fann YF, Hsu SH, Kuo KW and Lin CN: Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle. J Nat Prod 61: 485-487, 1998.
14. Min BS, Gao JJ, Nakamura N and Hattori M: Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharma Bull 48: 1026-1033, 2000.
15. Noda Y, Kaiya T, Kohda K and Kawazoe Y: Enhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: possibility of a new mode of cell killing. Chem Pharma Bull 45: 1665-1670, 1997.
16. Wu TS, Shi LS and Kuo SC: Cytotoxicity of Ganoderma lucidum triterpenes. J Nat Prod 64: 1121-1122, 2001.
17. Beauparlant P and Shore GC: Therapeutic activation of caspases in cancer: a question of selectivity. Curr Opin Drug Discov Devel 6: 179-187, 2003.
18. Thorburn A: Death receptor-induced cell killing. Cell Signal 16: 139-144, 2004.
19. Qi SN, Yoshida A, Wang ZR and Ueda T: GP7 can induce apoptotic DNA fragmentation of human leukemia cells through caspase-3-dependent and-independent pathways. Int J Mol Med 13: 163-167, 2004.
20. Zhang JF, Liu JJ, Liu PQ, Lin DJ, Li XD and Chen GH: Oridonin inhibits cell growth by induction of apoptosis on human hepatocelluar carcinoma BEL-7402 cells. Hepatol Res 35: 104-110, 2006.
21. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
22. Subramaniam V, Vincent IR and Jothy S: Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells. Exp Mol Pathol 79: 187-193, 2005.
23. Martin SJ, Reutelingsperger CP, McGahon AJ, et al: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182: 1545-1556, 1995.
24. Donepudi M and Grutter MG: Structure and zymogen activation of caspases. Biophys Chem 101-102: 145-153, 2002.
25. Denault JB and Salvesen GS: Caspases: keys in the ignition of cell death. Chem Rev 102: 4489-4500, 2002.
26. Boatright KM and Salvesen GS: Caspase activation. Biochem Soc Symp: 233-242, 2003.
27. Philchenkov AA: Caspases as regulators of apoptosis and other cell functions. Biochemistry 68: 365-376, 2003.
28. Huether A, Hopfner M, Sutter AP, Schuppan D and Scherubl H: Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics. J Hepatol 43: 661-669, 2005.
29. Nagata S: Apoptosis by death factor. Cell 88: 355-365, 1997.
30. Srinivasan A, Roth KA, Sayers RO, et al: In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 5: 1004-1016, 1998.
31. Tanabe H, Eguchi Y, Shimizu S, Martinou JC and Tsujimoto Y: Death-signalling cascade in mouse cerebellar granule neurons. Eur J Neurosci 10: 1403-1411, 1998.
32. Bhathena SJ and Velasquez MT: Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76: 1191-1201, 2002.
33. Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
34. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
35. Choi YH, Kong KR, Kim YA, et al: Induction of Bax and activation of caspases during β-sitosterol-mediated apoptosis in human colon cancer cells. Int J Oncol 23: 1657-1662, 2003.
36. Levy P, Robin H, Bertrand F, Kornprobst M and Capeau J: Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation. J Cell Physiol 197: 336-347, 2003.
37. White E: Life, death, and the pursuit of apoptosis. Genes Dev 10: 1-15, 1996.